Terms: = Ovarian cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras
248 results:
1. Identification of Germline
Pires C; Saramago A; Moura MM; Li J; Donato S; Marques IJ; Belo H; Machado AC; Cabrera R; Grünewald TGP; Leite V; Cavaco BM
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396644
[TBL] [Abstract] [Full Text] [Related]
2. Ferroptosis-Mediated Cell Death Induced by NCX4040, The Non-Steroidal Nitric Oxide Donor, in Human Colorectal cancer Cells: Implications in Therapy.
Sinha BK; Bortner CD; Jarmusch AK; Tokar EJ; Murphy C; Wu X; Winter H; Cannon RE
Cells; 2023 Jun; 12(12):. PubMed ID: 37371096
[TBL] [Abstract] [Full Text] [Related]
3. Acquisition of Genetic Aberrations During the Progression of High-Grade Intraepithelial Lesions/Micro-Invasive Squamous cancers to Widely Invasive Cervical Squamous Cell cancer.
Kashofer K; Reich O; Regauer S
Arch Pathol Lab Med; 2023 Dec; 147(12):1438-1445. PubMed ID: 36800542
[TBL] [Abstract] [Full Text] [Related]
4. Identification of key genes and pathways related to cancer-associated fibroblasts in chemoresistance of ovarian cancer cells based on GEO and TCGA databases.
Han L; Guo X; Du R; Guo K; Qi P; Bian H
J Ovarian Res; 2022 Jun; 15(1):75. PubMed ID: 35739532
[TBL] [Abstract] [Full Text] [Related]
5. MicroRNA-33b replacement effect on growth and migration inhibition in ovarian cancer cells.
Liu J; Wang W; Chen L; Li Y; Zhao S; Liang Y
Chem Biol Drug Des; 2023 May; 101(5):1019-1026. PubMed ID: 34590776
[TBL] [Abstract] [Full Text] [Related]
6. Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis.
Liu M; Wang D; Luo Y; Hu L; Bi Y; Ji J; Huang H; Wang G; Zhu L; Ma J; Kim E; Luo CK; Abbruzzese JL; Li X; Yang VW; Li Z; Lu W
Cell Death Dis; 2021 Feb; 12(2):189. PubMed ID: 33594044
[TBL] [Abstract] [Full Text] [Related]
7. Dual inhibition of FOXM1 and its compensatory signaling pathway decreased the survival of ovarian cancer cells.
Lee DW; Lee W; Kwon M; Lee HN
Oncol Rep; 2021 Jan; 45(1):390-400. PubMed ID: 33200225
[TBL] [Abstract] [Full Text] [Related]
8. mRNA expression in low grade serous ovarian cancer: Results of a nanoString assay in a diverse population.
Jordan SE; Saad H; Covarrubias AS; Siemon J; Pearson JM; Slomovitz BM; Huang M; Pinto A; Schlumbrecht M; George SH
Gynecol Oncol; 2020 Nov; 159(2):554-562. PubMed ID: 32951896
[TBL] [Abstract] [Full Text] [Related]
9. Papillary-cystic neoplasms of the middle ear are distinct from endolymphatic sac tumours.
Taverna C; Pollastri F; Pecci R; Giannoni B; Fattorini C; Santucci M; Mueller SK; Stoehr R; Franchi A; Agaimy A
Histopathology; 2021 Sep; 79(3):306-314. PubMed ID: 32940914
[TBL] [Abstract] [Full Text] [Related]
10. Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse model.
Taylan E; Zayou F; Murali R; Karlan BY; Pandol SJ; Edderkaoui M; Orsulic S
Gynecol Oncol; 2020 Oct; 159(1):277-284. PubMed ID: 32698955
[TBL] [Abstract] [Full Text] [Related]
11. ovarian mucinous tumors with mural nodules: immunohistochemical and molecular analysis of 3 cases.
Shao Y; Liu Q; Shi H; Lu B
Diagn Pathol; 2020 Apr; 15(1):35. PubMed ID: 32290854
[TBL] [Abstract] [Full Text] [Related]
12. Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors.
Desai J; Gan H; Barrow C; Jameson M; Atkinson V; Haydon A; Millward M; Begbie S; Brown M; Markman B; Patterson W; Hill A; Horvath L; Nagrial A; Richardson G; Jackson C; Friedlander M; Parente P; Tran B; Wang L; Chen Y; Tang Z; Huang W; Wu J; Zeng D; Luo L; Solomon B
J Clin Oncol; 2020 Jul; 38(19):2140-2150. PubMed ID: 32182156
[TBL] [Abstract] [Full Text] [Related]
13. DIRAS3 (ARHI) Blocks RAS/MAPK Signaling by Binding Directly to RAS and Disrupting RAS Clusters.
Sutton MN; Lu Z; Li YC; Zhou Y; Huang T; Reger AS; Hurwitz AM; Palzkill T; Logsdon C; Liang X; Gray JW; Nan X; Hancock J; Wahl GM; Bast RC
Cell Rep; 2019 Dec; 29(11):3448-3459.e6. PubMed ID: 31825828
[TBL] [Abstract] [Full Text] [Related]
14. Germline mutation and aberrant transcripts of WWOX in a syndrome with multiple primary tumors.
Xu A; Wang W; Nie J; Lui VW; Hong B; Lin W
J Pathol; 2019 Sep; 249(1):19-25. PubMed ID: 31056747
[TBL] [Abstract] [Full Text] [Related]
15. The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of FANCM pathogenic variants.
Schubert S; van Luttikhuizen JL; Auber B; Schmidt G; Hofmann W; Penkert J; Davenport CF; Hille-Betz U; Wendeburg L; Bublitz J; Tauscher M; Hackmann K; Schröck E; Scholz C; Wallaschek H; Schlegelberger B; Illig T; Steinemann D
Int J Cancer; 2019 Jun; 144(11):2683-2694. PubMed ID: 30426508
[TBL] [Abstract] [Full Text] [Related]
16. Fingolimod augments Pemetrexed killing of non-small cell lung cancer and overcomes resistance to ERBB inhibition.
Booth L; Roberts JL; Spiegel S; Poklepovic A; Dent P
Cancer Biol Ther; 2019; 20(5):597-607. PubMed ID: 30388910
[TBL] [Abstract] [Full Text] [Related]
17. Palbociclib augments Neratinib killing of tumor cells that is further enhanced by HDAC inhibition.
Booth L; Roberts JL; Rais R; Cutler RE; Diala I; Lalani AS; Poklepovic A; Dent P
Cancer Biol Ther; 2019; 20(2):157-168. PubMed ID: 30183517
[TBL] [Abstract] [Full Text] [Related]
18. The presence of KRAS, PPP2R1A and ARID1A mutations in 101 Chinese samples with ovarian endometriosis.
Zou Y; Zhou JY; Guo JB; Wang LQ; Luo Y; Zhang ZY; Liu FY; Tan J; Wang F; Huang OP
Mutat Res; 2018 May; 809():1-5. PubMed ID: 29547736
[TBL] [Abstract] [Full Text] [Related]
19. Mutational Aberrations Detected in Mucinous Epithelial ovarian cancer of Asian Women.
Chay WY; Kwok LL; Tiong WN; Krisna SS; Lim KH; Iyer NG; Goh LK; Tan DS
Int J Gynecol Cancer; 2018 Mar; 28(3):428-436. PubMed ID: 29465505
[TBL] [Abstract] [Full Text] [Related]
20. The levels of mutant k-ras and mutant n-ras are rapidly reduced in a Beclin1 / ATG5 -dependent fashion by the irreversible ERBB1/2/4 inhibitor neratinib.
Booth L; Roberts JL; Poklepovic A; Kirkwood J; Sander C; Avogadri-Connors F; Cutler RE; Lalani AS; Dent P
Cancer Biol Ther; 2018 Feb; 19(2):132-137. PubMed ID: 29219657
[TBL] [Abstract] [Full Text] [Related]
[Next]
